Real-world analysis of off-label semaglutide use for weight loss reveals user behavior patterns, effectiveness outside clinical trials, and adherence challenges.
Key findingReal-world analysis of off-label semaglutide use for weight loss reveals user behavior patterns, eff
What the researchers found
Real-world analysis of off-label semaglutide use for weight loss reveals user behavior patterns, effectiveness outside clinical trials, and adherence challenges.
Why it matters
This finding has implications for the millions of patients using or considering peptide-based therapies.
The numbers in context
74.6% of Kuwaiti adults are classified as overweight or obese. The survey captured usage patterns, weight changes, and satisfaction across Arab populations.
How the study worked
Clinical or preclinical study with methodology detailed in the full publication.
Who was studied
Adults in Arab populations using Ozempic off-label for weight loss
What this study cannot tell us
Study-specific limitations are discussed in the full publication. As with all research, findings should be interpreted in the context of study design and population.
How to read the evidence
Evidence grade assessment based on study design and methodology detailed in the full publication.
When this study was published
Published in 2025. Reflects current state of peptide therapeutic research.
The bigger picture
This study adds to the rapidly expanding evidence base for peptide-based therapeutics across multiple medical specialties.
Questions still open
- What are the long-term implications of these findings?
- How do these results compare to other studies in this area?
- What further research is needed to confirm and extend these findings?
Common questions
What does this study mean for patients?
How reliable are these findings?
Read the original research
Real-World Off-Label Use of Semaglutide for Weight Reduction: User Behavior, Effectiveness, and Satisfaction.
Patient preference and adherence, 19, 3373-3385
Citation
Al-Qaaneh, Ayman M; Qunaibi, Eyad A; Al-Fraihat, Natalia A; Abu-Aisheh, Baraa E; Rabea, Sameh; Al Aloul, Adnan A; Matahen, Rajaa; Annabi, Firas O. (2025). Real-World Off-Label Use of Semaglutide for Weight Reduction: User Behavior, Effectiveness, and Satisfaction.. Patient preference and adherence, 19, 3373-3385. https://doi.org/10.2147/PPA.S549716